Launch of Melanoma March 2021
1 March 2021
Not-for-profit organisation Melanoma Institute Australia (MIA) is calling on all Australians to join its innovative new Melanoma March campaign to raise awareness and funds to combat one of Australia’s biggest killers.
This year is the 10th anniversary of its national Melanoma March campaign. Due to COVID, the traditional family-friendly physical events have been replaced with an interactive digital campaign that all Australians can step up and take part in.
Everyone is asked to buy a $30 digital footprint in support of the one Aussie every 30 minutes who is told they have melanoma. Each footprint is then personalised with a message of support or hope, and shared to socials to spread the word.
Throughout the month of March, Melanoma Institute Australia wants to progressively cover its map of Australia with digital footprints, and in the process raise $500,000 for lifesaving research to develop new treatments for melanoma.
The interactive digital campaign goes live on Monday 1st March. To buy a digital footprint and see Australia be progressively covered in footprints, go to melanomamarch.org.au
Here's a short video to explain how it works:
Melanoma Institute Australia CEO Matthew Browne said just as melanoma can impact anyone - regardless of gender, age, skin type or where you live - anyone can take part in this year’s innovative digital Melanoma March campaign.
‘Melanoma is Australia’s national cancer, and no matter what part of this vast country we live in, we all have a responsibility to leave our footprint on melanoma and help save lives from this disease,’ Mr Browne said.
‘We want all Aussies to buy, personalise and share a digital footprint to support our ongoing research effort so we can reach our ultimate goal of zero deaths from melanoma.’
Australia has the highest melanoma rates in the world with one person diagnosed with the disease every 30 minutes. It is estimated 1300 people will die from melanoma in Australia this year. Melanoma is also the most common cancer affecting 15 to 39 year old Australians.
Melanoma March is an initiative of Melanoma Institute Australia, incorporating melanomaWA and Amie St Clair.
It is proudly supported by Melanoma Patients Australia, Australian Melanoma Research Foundation, Skin Cancer Tasmania and other melanoma research organisations across Australia.
For media enquiries, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | firstname.lastname@example.org
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.
Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.